# Percutaneous transhepatic recanalization of occluded prosthetic graft after pancreatoduodenectomy with venous reconstruction for pancreatic cancer

**Authors:** Nils Degrauwe, Didier Roulin, Vincent Dunet, Nermin Halkic, Nicolas Demartines, Antonia Digklia, Nicolas Villard, Alban Denys, Georgia Tsoumakidou, Rafael Duran

PMC · DOI: 10.3389/fonc.2025.1575481 · Frontiers in Oncology · 2025-07-17

## TL;DR

This study shows that a minimally invasive procedure can safely restore blood flow in blocked grafts after pancreatic cancer surgery, with small graft sizes being a key risk factor for blockage.

## Contribution

Demonstrates the feasibility and safety of percutaneous transhepatic recanalization for occluded prosthetic grafts after pancreatic surgery.

## Key findings

- Percutaneous transhepatic recanalization achieved 100% technical success with no complications.
- Small postoperative graft diameter and caudal anastomosis diameter were significant predictors of graft occlusion.
- Occlusion was symptomatic in 86% of cases and linked to tumor recurrence in 43% of patients.

## Abstract

To investigate the feasibility, safety, and efficacy of percutaneous transhepatic endovascular recanalization and stenting after venous graft thrombosis in pancreatic cancer patients who underwent pancreatoduodenectomy (PD) with venous reconstruction and assess risk factors of occlusion.

This retrospective study was approved by the institutional review board. The clinical characteristics of 227 patients who underwent PD were compared among patients who underwent PD with/without porto-mesenteric venous resection (PMVR) ± prosthetic graft interposition.

Out of 227 patients, 18 (8%) underwent PD with PMVR and prosthetic graft interposition. Seven out of 18 patients had prosthetic graft occlusion. Occlusion was symptomatic in most cases (86%) and associated with tumor recurrence in 43%. On univariable logistic regression analysis, small postoperative graft diameter (OR: 0.141; 95% CI 0.021–0.970) and caudal anastomosis diameter measured on CT (OR: 0.226; 95% CI 0.059–0.859) were clear predictors of graft occlusion (p = 0.047 and p = 0.029, respectively). Interventional recanalization was performed in five patients. Technical success was 100%, with no complications.

Percutaneous transhepatic prosthetic graft recanalization and stenting is feasible and may be considered a safe and effective technique with immediate restoration of porto-mesenteric blood flow and symptom relief. Small grafts and venous anastomosis diameters are particularly at risk of thrombosis.

## Linked entities

- **Diseases:** pancreatic cancer (MONDO:0005192)

## Full-text entities

- **Diseases:** pancreatic cancer (MESH:D010190), Occlusion (MESH:D001157), tumor (MESH:D009369), venous graft thrombosis (MESH:D020246), thrombosis (MESH:D013927)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12310483/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12310483/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12310483/full.md

---
Source: https://tomesphere.com/paper/PMC12310483